Namur Research Institute for Life Sciences (NARILIS), Integrated Veterinary Research Unit (URVI), University of Namur, Namur, Belgium.
J Virol. 2021 Jun 10;95(13):e0241320. doi: 10.1128/JVI.02413-20.
Human adenoviruses (HAdVs) are a large family of DNA viruses that include more than 100 genotypes divided into seven species (A to G) and induce respiratory tract infections, gastroenteritis, and conjunctivitis. Genetically modified adenoviruses are also used as vaccines, gene therapies, and anticancer treatments. The APOBEC3s are a family of cytidine deaminases that restrict viruses by introducing mutations in their genomes. Viruses developed different strategies to cope with the APOBEC3 selection pressure, but nothing is known on the interplay between the APOBEC3s and the HAdVs. In this study, we focused on three HAdV strains: the B3 and C2 strains, as they are very frequent, and the A12 strain, which is less common but is oncogenic in animal models. We demonstrated that the three HAdV strains induce a similar APOBEC3B upregulation at the transcriptional level. At the protein level, however, APOBEC3B is abundantly expressed during HAdV-A12 and -C2 infection and shows a nuclear distribution. On the contrary, APOBEC3B is barely detectable in HAdV-B3-infected cells. APOBEC3B deaminase activity is detected in total protein extracts upon HAdV-A12 and -C2 infection. Bioinformatic analysis demonstrates that the HAdV-A12 genome bears a stronger APOBEC3 evolutionary footprint than that of the HAdV-C2 and HAdV-B3 genomes. Our results show that HAdV infection triggers the transcriptional upregulation of the antiviral innate effector APOBEC3B. The discrepancies between the APOBEC3B mRNA and protein levels might reflect the ability of some HAdV strains to antagonize the APOBEC3B protein. These findings point toward an involvement of APOBEC3B in HAdV restriction and evolution. The APOBEC3 family of cytosine deaminases has important roles in antiviral innate immunity and cancer. Notably, APOBEC3A and APOBEC3B are actively upregulated by several DNA tumor viruses and contribute to transformation by introducing mutations in the cellular genome. Human adenoviruses (HAdVs) are a large family of DNA viruses that cause generally asymptomatic infections in immunocompetent adults. HAdVs encode several oncogenes, and some HAdV strains, like HAdV-A12, induce tumors in hamsters and mice. Here, we show that HAdV infection specifically promotes the expression of the APOBEC3B gene. We report that infection with the A12 strain induces a strong expression of an enzymatically active APOBEC3B protein in bronchial epithelial cells. We provide bioinformatic evidence that HAdVs' genomes and notably the A12 genome are under APOBEC3 selection pressure. Thus, APOBEC3B might contribute to adenoviral restriction, diversification, and oncogenic potential of particular strains.
人腺病毒(HAdV)是一个庞大的 DNA 病毒家族,包含 100 多种基因型,分为七个种(A 至 G),可引起呼吸道感染、胃肠炎和结膜炎。遗传修饰的腺病毒也被用作疫苗、基因治疗和抗癌治疗。APOBEC3 是一个胞嘧啶脱氨酶家族,通过在其基因组中引入突变来限制病毒。病毒发展出不同的策略来应对 APOBEC3 的选择压力,但对于 APOBEC3 和 HAdV 之间的相互作用还一无所知。在这项研究中,我们重点研究了三种 HAdV 株:B3 和 C2 株,因为它们非常常见,而 A12 株则不太常见,但在动物模型中具有致癌性。我们证明,三种 HAdV 株在转录水平上诱导相似的 APOBEC3B 上调。然而,在蛋白质水平上,APOBEC3B 在 HAdV-A12 和 -C2 感染期间大量表达,并表现出核分布。相反,在 HAdV-B3 感染的细胞中几乎检测不到 APOBEC3B。在 HAdV-A12 和 -C2 感染后,可在总蛋白提取物中检测到 APOBEC3B 脱氨酶活性。生物信息学分析表明,HAdV-A12 基因组比 HAdV-C2 和 HAdV-B3 基因组具有更强的 APOBEC3 进化足迹。我们的结果表明,HAdV 感染触发抗病毒先天效应物 APOBEC3B 的转录上调。APOBEC3B mRNA 和蛋白质水平之间的差异可能反映了一些 HAdV 株拮抗 APOBEC3B 蛋白的能力。这些发现表明 APOBEC3B 参与了 HAdV 的限制和进化。胞嘧啶脱氨酶 APOBEC3 家族在抗病毒先天免疫和癌症中具有重要作用。值得注意的是,APOBEC3A 和 APOBEC3B 被几种 DNA 肿瘤病毒积极上调,并通过在细胞基因组中引入突变促进转化。人腺病毒(HAdV)是一种大型 DNA 病毒家族,可导致免疫功能正常的成年人无症状感染。HAdV 编码几个致癌基因,一些 HAdV 株,如 HAdV-A12,可在仓鼠和小鼠中诱导肿瘤。在这里,我们表明 HAdV 感染特异性地促进 APOBEC3B 基因的表达。我们报告说,A12 株感染可诱导支气管上皮细胞中大量表达具有酶活性的 APOBEC3B 蛋白。我们提供了生物信息学证据,表明 HAdV 基因组,特别是 A12 基因组受到 APOBEC3 的选择压力。因此,APOBEC3B 可能有助于腺病毒的限制、多样化和特定株的致癌潜力。